Carregant...
Additive melanoma suppression with intralesional phospholipid conjugated TLR7 agonists and systemic IL-2
OBJECTIVE: There remains a compelling need for the development of treatments for unresectable melanoma. Agents that stimulate the innate immune response could provide advantages for cell based therapies. However there are conflicting reports concerning whether Toll-like receptor (TLR) signaling cont...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3057341/ https://ncbi.nlm.nih.gov/pubmed/21030882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0b013e328340ce6c |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|